Posted by Staff Writer on 4/14/2021 to Healthcare
Johnson & Johnson New Jersey Notice
IncSmart New Jersey (Small Business and Startups) - Johnson & Johnson has been recommend to pause administering the Covid19 vaccine by the CDC and the FDA. The health departments want to review data involving six reported U.S. cases out of more than 6.8 million doses administered. Johnson & Johnson Statement on COVID-19 Vaccine (Updated) | Johnson & Johnson (jnj.com) "We have made the decision to proactively delay the rollout of our vaccine in Europe and pause vaccinations in all Janssen COVID-19 vaccine clinical trials while we update guidance for investigators and participants".